收缩:有胎盘的孕妇中的特兰胺酸 之前:一项双盲多中心随机临床试验
Shahla Alalaf1, Ariana K Jawad2, Namir G Al-Tawil3
1Obstetrics and Gynecology, Hawler Medical University, College of Medicine, Erbil, IRQ.
Cureus
|November 14, 2025
概括
这篇文章已被撤回. 原始研究不再可供审查或引用.
科学领域:
- 撤回通知 撤回通知
- 科学出版的伦理科学出版的伦理.
背景情况:
- 标识DOI: 10.7759/cureus.75297的物品已经被收回.
研究的目的:
- 正式宣布撤回之前发表的文章.
主要方法:
- 撤回根据期刊的编辑政策进行处理.
主要成果:
- 该文章不再被认为是科学记录的一部分.
结论:
- 读者应该忽略在撤回的文章中提出的所有发现和结论.
相关概念视频
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K


